Welcome from the Division Chief
Welcome to the website for the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University. We are incredibly proud of our tradition and accomplishments in contributing to the advancement of treatment of infectious diseases locally, nationally and worldwide.
Our core mission is to heal, to teach and to discover. Facing the challenges of emerging and re-emerging infectious diseases at home and across the globe; we pride ourselves on delivering the highest quality of care for our patients, providing exceptional fellowship training to the next generation of Infectious Diseases physicians and continuing to make scientific breakthroughs through our world renowned research.
CWRU wins $12.7 million for AIDS research, clinical trials
AIDS researchers from Case Western Reserve University and University Hospitals Case Medical Center have received a seven-year funding award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
This award includes $12.7 million for core research funding and the potential of an additional $9 million to support clinical trials of promising treatments. This award marks the fifth time the Case Western Reserve University (CWRU)/University Hospitals (UH) AIDS Clinical Trials Unit has received NIAID funding since it began operating in 1987.
"We are very proud to have received this competitive award," said co-principal investigator Michael Lederman, the Scott R. Inkley Professor of Medicine and associate director of the Center for AIDS Research at Case Western Reserve School of Medicine and infectious disease specialist at UH Case Medical Center. "It shows a level of confidence in our unit that encourages and inspires us." Read more...
CWRU researchers heading teams chosen by amfAR to pursue research for eradicating HIV and AIDS
By Angela Townsend, The Plain Dealer CLEVELAND, Ohio -- Two Case Western Reserve University scientists are each heading up research teams chosen by New York-based amfAR, The Foundation for AIDS Research, to receive funding for projects aimed at eliminating AIDS. The group this week announced more than $900,000 in grants that will be divided among five teams. The latest round of awards is part of amfAR's Research Consortium on HIV Eradication (ARCHE) program launched in 2010. Read the article.
STERIS Grant 2013 Awardees
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, are providing seed money to faculty to foster research in emerging and healthcare-associated infections. Investigators in the basic science and clinical departments in the School of Medicine and Hospital System as well as in other departments throughout the University were awarded. Awardees are as follows:
- Christine McDonald, PhD - Department of Pathobiology - Enhancement of cutaneous antimicrobial defenses to target MRSA infection
- Pushpa Pandiyan, MSc, PhD - School of Dental Medicine - A mechanism of immunomodulation during Oropharyngeal candidiasis
- Daniel Popkin, MD, PhD; Nicole Steinmetz, PhD (Co-PI) - Dermatology | Pathology | Microbiology & Molecular Biology (Popkin); Biomedical Engineering | Radiology | Materials Science and Engineering (Steinmetz) - Purging persistent viral infection with nanoparticle "seek and protect" therapy of pAPC
- Roxana Rojas, PhD - Infectious Diseases & HIV Medicine - Host oxidoreductases as targets of TB drugs
- Marion Skalweit, MD, PhD - Infectious Diseases & HIV Medicine - Bulgecin A for Resistant Gram-negatives
ClinicalRM Awarded NIH Contract to Support the STI CTG Program
September 10, 2013, Hinckley, OH – Clinical Research Management, Inc. (ClinicalRM) – a full-service Contract Research Organization (CRO) providing services for basic and applied research, clinical trials, and regulatory support – announced today it was awarded a contract by the Department of Health and Human Services, National Institutes of Health, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). Read the article.